And a much bigger market, which is based on remediation rather than cure.
- Forums
- ASX - By Stock
- CYP
- Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX
Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX, page-8
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.99M |
Open | High | Low | Value | Volume |
27.0¢ | 29.5¢ | 27.0¢ | $3.372K | 11.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 39000 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 1608 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 39000 | 0.280 |
1 | 10000 | 0.275 |
1 | 11111 | 0.270 |
1 | 95000 | 0.265 |
2 | 79000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 1608 | 1 |
0.305 | 17853 | 1 |
0.310 | 16591 | 3 |
0.325 | 15000 | 1 |
0.340 | 100000 | 1 |
Last trade - 11.40am 01/07/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online